Gland Pharma Limited has intimated the stock exchanges about an upcoming meeting of its Board of Directors. The meeting is scheduled to be held on Monday, August 10, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
Trading Window Closure
In continuation of a prior intimation dated June 26, 2026, the company confirms that the trading window for dealing in the company's securities was closed for all insiders from Saturday, June 27, 2026. This closure was in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The trading window is scheduled to reopen on Thursday, August 13, 2026.
Earnings Call
The company has scheduled an Investor/Analyst call to discuss the results on Monday, August 10, 2026, at 18:30 Hrs (IST). The detailed information regarding this call, including access details, will be communicated to the stock exchanges and published on the company's official website (www.glandpharma.com) in due course.
The disclosure was signed by Sampath Kumar Pallerlamudi, Company Secretary & Compliance Officer, from the company's registered office in Hyderabad, Telangana.